Coronary Artery Fistula and Severe Coronary Artery Stenosis: A Case Report and an Insight for Potential Pathogenesis of Coronary Artery Atherosclerosis.
Jinchun LiuZhijun YuGuo-Hua WangPublished in: International medical case reports journal (2024)
Coronary artery fistulae (CAF) are a rare anomaly characterized by abnormal connections between a coronary artery and a cardiac chamber or a great vessel, with most patients remaining asymptomatic. Despite being predisposed to severe complications like heart failure, patients with CAF infrequently experience severe stenosis in the coronary artery. This study delineates a case involving a 46-year-old male presenting with a fistula bridging the right coronary artery (RCA) and right atrium (RA), manifesting a pronounced 99% stenosis at the right extremity of the coronary artery proximal to the fistula. Concurrently, the individual exhibits six conventional risk factors: age over 40, male gender, hypertension, diabetes, smoking, and hypertriglyceridemia. Following pharmaceutical intervention, the patient was discharged and subjected to extended follow-up. This case highlights the dual processes of "accelerating damage" and "retarding renewal" in the progression of atherosclerosis. Factors such as shear stress, smoking, and hypertension are posited to expedite endothelial cell damage, while aging and diabetes may impede the renewal and repair of these cells. Together with the concept of secondary atherosclerotic plaque healing, this case prompts the introduction of a "Double Endothelial Healings" hypothesis, proposing a potential pathogenetic mechanism for coronary artery atherosclerosis.
Keyphrases
- coronary artery
- pulmonary artery
- heart failure
- cardiovascular disease
- risk factors
- blood pressure
- type diabetes
- randomized controlled trial
- pulmonary hypertension
- oxidative stress
- risk assessment
- cell proliferation
- systemic sclerosis
- systemic lupus erythematosus
- insulin resistance
- pulmonary embolism
- soft tissue
- weight loss
- climate change
- glycemic control
- ankylosing spondylitis
- atrial fibrillation